Charcot-Marie-Tooth Neuropathy Type 2U (CMT2U)

Charcot-Marie-Tooth neuropathy type 2U (CMT2U) is a very rare inherited nerve disease where the long nerves in the arms and legs slowly become damaged, especially their axons (the “wires” that carry signals). This causes late-adult onset numbness, tingling, weakness and muscle wasting in the hands and feet, and it gets worse very slowly over many years. NCBI+1

Charcot-Marie-Tooth neuropathy type 2U (CMT2U) is a very rare inherited nerve disease. It belongs to the “type 2” group, which means the main problem is in the long part of the nerve fiber (the axon), not the myelin covering. In CMT2U, a fault (mutation) in the MARS1 gene on chromosome 12 changes how a protein that helps build new proteins in the cell works. This slowly damages nerves in the legs and arms, causing weakness, muscle wasting, foot deformities, and balance problems. There is no cure yet, so treatment focuses on keeping muscles working as well as possible, reducing pain, and preventing disability, using the same principles as for other CMT2 types. MalaCards+3ZFIN+3Monarch Initiative+3

CMT2U is an axonal type of Charcot-Marie-Tooth disease (CMT2) and follows an autosomal dominant pattern. That means one changed copy of the gene is enough to cause the disease, and it often runs in families. Symptoms usually start around 50–60 years of age, much later than many other forms of CMT. MalaCards+1

Scientists have found that CMT2U is usually caused by a harmful change (mutation) in a gene called MARS1, which gives instructions for an enzyme called methionyl-tRNA synthetase. This enzyme is important for building proteins inside nerve cells. When the enzyme does not work properly, long peripheral nerves slowly lose function and start to degenerate. MalaCards+1

Because CMT2U affects the peripheral nerves, it is part of the larger CMT group, also called hereditary motor and sensory neuropathies. In these disorders, people often have high-arched feet, hammertoes, foot drop, weak ankles, and later weakness in the hands, with reduced reflexes and loss of feeling. NCBI+2Mayo Clinic+2

---

Other names

Doctors and researchers may use several different names for CMT2U. They all refer to the same rare disease: NCBI+2MalaCards+2

• Charcot-Marie-Tooth disease, axonal, type 2U

• Charcot-Marie-Tooth neuropathy type 2U

• Autosomal dominant Charcot-Marie-Tooth disease type 2U

• Autosomal dominant axonal Charcot-Marie-Tooth disease type 2U

• Charcot-Marie-Tooth type 2 due to MARS mutation

• CMT2U

More general names that may be used in clinic notes (for many CMT types, not only CMT2U) include hereditary motor and sensory neuropathy (HMSN) and peroneal muscular atrophy. nhs.uk+1

---

Types (clinical patterns)

CMT2U is defined as one genetic subtype, but reported patients show a few patterns. These are not official separate diseases but helpful ways to describe what doctors see. MalaCards+1

• Typical late-adult CMT2U – symptoms start around 50–60 years with slowly worsening numbness and weakness in hands and feet, matching the classic description in families first reported with MARS1 mutations. MalaCards+1

• Early-onset or congenital CMT2U – a few case reports describe people with MARS1 mutations who had neuropathy signs from birth or early childhood, showing that onset can sometimes be much earlier than the usual adult pattern. MalaCards+1

• CMT2U with extra (systemic) features – some MARS1 variants have been linked to additional lung and liver disease, growth problems, or anemia, so doctors may see CMT2U together with other organ problems in the same patient. MalaCards+1

• CMT2U with prominent pain – Orphanet and other summaries note that neuropathic pain can be a feature, so some people mainly complain of burning or shooting pain in the feet and hands, in addition to weakness. MalaCards+1

• CMT2U with mainly distal upper-limb problems – descriptions mention strong involvement of hand and forearm muscles, so some patients may notice hand clumsiness and finger weakness as major early signs. MalaCards+1

---

Causes

Before listing many “causes”, it is important to remember that the true primary cause of CMT2U is a genetic change in the MARS1 gene. Other points below describe how this mutation damages nerves and which extra factors can make neuropathy worse; they do not replace the main genetic cause. MalaCards+1

1. Pathogenic MARS1 mutation – CMT2U happens when one copy of the MARS1 gene has a harmful mutation. This single change is enough to disturb nerve function and create the disease, usually in an autosomal dominant pattern. MalaCards+1

2. Faulty methionyl-tRNA synthetase enzyme – MARS1 encodes methionyl-tRNA synthetase, which attaches the amino acid methionine to its tRNA in protein synthesis. A mutation can make this enzyme less accurate or less active, disturbing protein building in neurons. MalaCards+1

3. Toxic gain-of-function of MARS1 – Some studies suggest that mutant tRNA-synthetase proteins may gain new toxic properties, for example abnormal interactions with other cell pathways, leading to nerve damage beyond simple loss of function. MalaCards+1

4. Impaired protein synthesis in neurons – If methionyl-tRNA synthetase does not work well, nerve cells may make proteins more slowly or incorrectly. Long peripheral nerves need a constant supply of proteins along the axon; disruption can lead to gradual degeneration. MalaCards+1

5. Axonal degeneration of peripheral nerves – CMT2U belongs to the axonal group of CMT. Nerve conduction studies show relatively preserved speeds but reduced signal size, which reflects loss of axons rather than loss of myelin. NCBI+1

6. “Dying-back” of long distal axons – The longest nerves to the feet and hands are most vulnerable, so damage starts distally and “creeps” upward. This “dying-back” pattern is common in axonal neuropathies and explains why symptoms first appear in the feet. NCBI+1

7. Disrupted axonal transport – Axons must transport energy sources, proteins, and cell parts over long distances. Many CMT2 conditions, including tRNA-synthetase-related forms, are thought to disturb axonal transport, leading to energy failure and structural breakdown. NCBI+1

8. Secondary Schwann-cell and myelin changes – Even though CMT2U is primarily axonal, axon damage can secondarily disturb Schwann cells and myelin sheaths that support the nerve, causing further weakness and sensory loss over time. NCBI+1

9. Slow cumulative axonal loss – CMT2U is described as slowly progressive with late-adult onset, which suggests that small amounts of axonal damage accumulate for decades before symptoms become obvious in mid-life. MalaCards+1

10. Autosomal dominant inheritance from a parent – Because the disorder is autosomal dominant, each child of an affected person has about a 50% chance to inherit the mutated gene and eventually develop neuropathy. MalaCards+1

11. De novo MARS1 mutation – In some cases, the mutation appears for the first time in a person, without a family history. This happens when a new error arises in the egg or sperm or early embryo. MalaCards+1

12. Other variants in tRNA-synthetase genes – Research on inherited neuropathies shows that several tRNA-synthetase genes (for example GARS, YARS) can cause CMT-like diseases. This suggests that subtle differences in these pathways might modify how MARS1 mutations behave. MalaCards+1

13. Age-related decline in nerve repair – As people age, nerve regeneration becomes less efficient. In someone with a MARS1 mutation, this natural decline may help explain why symptoms typically show up only in later adult life. NCBI+1

14. Coexisting diabetes (modifier, not primary cause) – Diabetes is a common cause of axonal neuropathy. If a person with CMT2U also has diabetes, the high blood sugar can add extra nerve damage, making symptoms more severe, even though it does not create CMT2U by itself. Physiopedia+1

15. Long-term alcohol misuse (modifier) – Chronic heavy alcohol use can injure peripheral nerves. In a person with CMT2U, alcohol-related damage may worsen numbness and weakness on top of the inherited axonal loss. Physiopedia+1

16. Vitamin B12 or folate deficiency (modifier) – Lack of key vitamins for nerve health, particularly B12 and folate, can cause additional neuropathy. Treating these deficiencies will not cure CMT2U but may prevent extra avoidable nerve injury. Physiopedia+1

17. Neurotoxic chemotherapy drugs (modifier) – Certain cancer drugs, such as some vinca alkaloids and platinum agents, are known to cause peripheral neuropathy. If they are given to someone with CMT, they may cause more pronounced nerve damage than in people without CMT. Physiopedia+1

18. Mechanical stress and foot deformities – Weak muscles and high-arched feet alter the way forces pass through the feet and ankles. Over time, this can compress nerves, stretch them abnormally, and worsen symptoms like pain and numbness. Mayo Clinic+1

19. Smoking and poor circulation (modifier) – Smoking and blood-vessel disease reduce blood flow to peripheral nerves. In a person whose nerves are already fragile from CMT2U, low blood flow can speed up axonal loss and delay healing after small injuries. Physiopedia+1

20. Unknown genetic and environmental modifiers – Case reports show that even within one family, some people with the same MARS1 mutation are more severely affected than others, suggesting that extra genes or environmental factors also shape the final disease pattern. MalaCards+1

---

Symptoms

1. Distal sensory loss (numbness) – The first clear sign is often reduced feeling in the toes and fingers, described as “numb” or “wearing thick socks or gloves.” This matches the description of distal pan-modal sensory impairment in CMT2U. MalaCards+1

2. Paresthesia (tingling or pins and needles) – People may feel tingling, burning, or “electric” sensations in the feet and hands. These abnormal feelings are typical of axonal sensory neuropathy and are frequently reported in CMT. Mayo Clinic+1

3. Neuropathic pain – Some individuals with CMT2U experience sharp, burning, or shooting pain, especially in the legs and feet. Orphanet specifically notes neuropathic pain as a possible feature, which can seriously affect quality of life. MalaCards+1

4. Distal muscle weakness in the legs – Weakness usually begins in the muscles that lift the foot and ankle, making it hard to climb stairs or walk on uneven ground. This distal weakness is a hallmark of axonal CMT. MalaCards+1

5. Foot drop and tripping – Because ankle muscles are weak, the front of the foot may drag during walking (foot drop). Patients often catch their toes on the ground and trip frequently, leading to falls. Mayo Clinic+1

6. Muscle wasting in lower legs (“stork legs”) – Over years, the calf muscles shrink, and the lower legs can look thin compared with the thighs. This distal muscle atrophy is commonly described in CMT. nhs.uk+1

7. Foot deformities (high arches and hammertoes) – Imbalance between weak and stronger muscles can pull the foot into a high arched shape (pes cavus) with curled toes, which is typical of many CMT types. Mayo Clinic+1

8. Hand and forearm weakness – As disease progresses, people may notice difficulty opening jars, gripping objects, or doing fine tasks such as buttoning shirts, reflecting distal muscle weakness in the upper limbs. MalaCards+1

9. Hand muscle wasting – Small muscles between the fingers may slowly shrink, giving a bony appearance to the hands. This pattern is frequently seen in chronic CMT neuropathies. NCBI+1

10. Loss of tendon reflexes – Reflexes at the ankles and knees are often reduced or absent because the reflex arc needs healthy sensory and motor axons, which are damaged in CMT2U. MalaCards+1

11. Balance problems and unsteady gait – Loss of position sense in the feet, plus weakness, makes it hard to stay steady, especially in the dark or on uneven surfaces. People may walk with a wide-based or high-stepping gait to prevent falls. Mayo Clinic+1

12. Clumsiness and poor fine motor control – Tasks like writing, typing, or using tools can become slow or awkward because of hand weakness and reduced feeling in the fingertips. NCBI+1

13. Fatigue and reduced walking distance – Because muscles are weak and nerves work less efficiently, everyday actions require more effort, so people may feel tired after short walks or basic activities. Mayo Clinic+1

14. Cramps and muscle stiffness – Some patients report painful cramps or stiffness in calves or hands, especially after activity. This is common in many neuropathies and may relate to unstable nerve signals to muscles. Physiopedia+1

15. Slow but progressive course – In CMT2U, symptoms typically worsen slowly over many years. People may stay able to walk independently for a long time, but progression can eventually require braces or walking aids. MalaCards+1

---

Diagnostic tests

Physical exam

1. Detailed neurological examination – The doctor checks strength, reflexes, muscle bulk, and different kinds of sensation (light touch, pinprick, vibration) in arms and legs. In CMT2U, they usually find distal weakness, muscle wasting, reduced reflexes, and sensory loss in a “glove and stocking” pattern. NCBI+1

2. Gait and functional assessment – The clinician watches how the person walks, turns, climbs on toes and heels, and rises from a chair. A high-stepping gait, foot drop, and difficulty with heel-walking are common signs in CMT-type neuropathies. Mayo Clinic+1

3. Inspection of feet and hands – The doctor looks for high arches, hammertoes, calluses, ankle instability, and wasting of small hand muscles. These structural changes point toward a long-standing hereditary neuropathy rather than a sudden acquired problem. nhs.uk+1

4. Balance and coordination tests – Simple bedside tests like standing with feet together and eyes closed (Romberg test) or walking heel-to-toe can show how much sensory loss and weakness are affecting balance. People with CMT often sway or need support during these tasks. NCBI+1

---

Manual bedside tests

5. Manual muscle testing (MRC grading) – The examiner grades strength of ankle, toe, wrist, and finger muscles by pressing against the patient’s movement. In CMT2U, distal muscles are clearly weaker than proximal muscles, supporting a length-dependent neuropathy. Physiopedia+1

6. Vibration sense with tuning fork – A vibrating tuning fork is placed on toes and ankles to check large-fiber sensory function. Reduced or absent vibration sense in the feet is typical in axonal CMT and helps quantify sensory loss at the bedside. NCBI+1

7. Pinprick and light-touch mapping – Using a pin and cotton, the doctor compares feeling in distal and proximal skin areas. A clear gradient of reduced pinprick and touch from toes upwards is a classic sensory pattern in CMT2U and other length-dependent neuropathies. NCBI+1

8. Joint position sense testing – The examiner gently moves the big toe or finger up and down and asks the patient to report the direction with closed eyes. Poor joint position sense in toes and fingers confirms large-fiber sensory involvement in CMT. NCBI+1

---

Lab and pathological tests

9. Routine blood tests for other neuropathy causes – Doctors often check blood sugar, vitamin B12, folate, thyroid function, kidney and liver tests, and sometimes autoimmune markers. In pure CMT2U these are usually normal, but they are important to rule out common acquired neuropathies that can mimic or worsen CMT. ARUP Consult+1

10. Targeted or panel genetic testing for CMT – Modern testing uses multi-gene panels or exome sequencing to look for mutations in many CMT genes, including MARS1. Finding a pathogenic MARS1 variant in a person with a matching clinical picture confirms the diagnosis of CMT2U. Louisiana Department of Health+2ARUP Consult+2

11. Family genetic studies – When a MARS1 mutation is found, other family members may be offered testing. Seeing the same mutation in affected relatives and not in unaffected relatives supports autosomal dominant inheritance of CMT2U in that family. MalaCards+1

12. Nerve biopsy (selected cases) – A small piece of a sensory nerve (often the sural nerve) may be taken and examined under a microscope. In axonal CMT, biopsy shows loss of axons with relatively preserved myelin. This is now used less often because genetic testing is more precise, but it can still help when genetic results are unclear. NCBI+1

---

Electrodiagnostic tests

13. Nerve conduction studies (NCS) – Electrodes stimulate and record from nerves in arms and legs. In CMT2 forms, conduction speeds are normal or only mildly slowed, but the response sizes (amplitudes) are reduced, showing axonal loss. This pattern helps distinguish CMT2U from demyelinating forms like CMT1. Charcot-Marie-Tooth Association+1

14. Electromyography (EMG) – A thin needle electrode is placed in muscles to record electrical activity. EMG in CMT2U often shows chronic denervation and reinnervation, reflecting long-standing axonal damage and attempts at muscle re-innervation. NCBI+1

15. Motor unit number estimation (MUNE) – Research studies in CMT use MUNE to estimate how many functioning motor units remain in a muscle. It can detect subclinical axonal loss that is not visible on routine exam or simple NCS, giving a more sensitive measure of disease severity. PubMed+1

16. Somatosensory evoked potentials (optional) – In some centers, electrical responses from the brain after skin stimulation are measured. Delayed or reduced signals can show how far sensory pathways are affected, although this is less commonly needed than NCS and EMG. NCBI+1

---

Imaging tests

17. Foot and ankle X-rays – Plain radiographs can show high arches, hammertoes, and misalignment of joints. These images help orthopedic planning for braces or surgery and confirm that deformities are long-standing and structural. Mayo Clinic+1

18. Spine X-ray or MRI (if scoliosis or other issues) – Some people with CMT develop spine curvature or other skeletal changes. Imaging helps evaluate back pain, deformity, or suspected spinal cord problems that may add to weakness or numbness. NCBI+1

19. Muscle MRI or ultrasound – Imaging of leg and hand muscles can show patterns of muscle wasting and fatty replacement typical of chronic neuropathy. These patterns can support the diagnosis and help distinguish neuropathies from primary muscle diseases. Physiopedia+1

20. Chest and abdominal imaging (selected MARS1 cases) – Because some MARS1 mutations are linked to lung and liver problems, doctors may order CT or MRI scans of chest and abdomen in people who have breathing issues or abnormal liver tests, to look for related organ involvement. MalaCards+1

Non-Pharmacological Treatments

1. Structured physical therapy program
A regular physical therapy program is the heart of CMT2U care. A physiotherapist designs gentle stretching, strengthening, and endurance exercises to keep muscles moving and joints flexible. The purpose is to delay contractures, maintain walking ability, and reduce pain and fatigue. The main mechanism is repeated, safe loading of muscles and nerves, which helps preserve strength and coordination even as the disease progresses. Journal of Health and Allied Sciences NU+3nhs.uk+3Physiopedia+3

2. Occupational therapy for daily activities
Occupational therapists teach easier ways to dress, write, cook, and work with weak hands and feet. The purpose is to keep independence at home, school, and work. They may suggest different grips, special pens, or kitchen tools. The mechanism is activity “adaptation”: changing tasks, tools, and body positions so the person uses less force and reduces strain on weak muscles while still staying active. PMC+1

3. Ankle–foot orthoses (AFOs)
AFOs are light braces worn in shoes to support the ankle and foot. In CMT2U they help control foot drop, improve step height, and reduce tripping. The purpose is safer walking with less effort. Mechanically, AFOs hold the ankle in a stable position, store and release energy during steps, and prevent the toes from dragging, which protects joints and lowers fall risk. nhs.uk+2ScienceDirect+2

4. Custom footwear and insoles
Custom shoes and insoles support high arches, hammer toes, and wide or unstable feet. The purpose is to reduce pressure points, calluses, and pain while walking. The mechanism is redistribution of weight across the sole, better alignment of the heel and forefoot, and more stable contact with the ground, which improves balance and reduces falls. nhs.uk+2Physiopedia+2

5. Stretching and contracture-prevention program
Daily stretching of ankles, calves, hamstrings, and fingers helps keep joints moving. The purpose is to delay or limit fixed deformities that make walking, standing, and using hands difficult. The mechanism is slow, regular lengthening of muscles and tendons, which keeps them from shortening as weaker muscles stop moving through full range. nhs.uk+2PMC+2

6. Targeted strength training
Low-to-moderate resistance training can strengthen muscles that are not yet severely damaged. The purpose is to improve walking speed, stair climbing, and hand grip without over-fatiguing weak nerves. The mechanism is progressive overload of remaining muscle fibers, which increases muscle size and neuromuscular efficiency while avoiding very heavy weights that may overstrain compromised axons. Physiopedia+2PMC+2

7. Balance and proprioception training
Balance exercises (tandem standing, single-leg standing with support, foam surfaces) help the brain use vision and remaining sensation more effectively. The purpose is to reduce falls and improve confidence when walking in crowds or on uneven ground. The mechanism is repeated practice of body-position control, which trains central nervous system pathways to compensate for weak and numb ankles. PMC+2Journal of Health and Allied Sciences NU+2

8. Aquatic (water) therapy
Exercises in warm water let people move weak limbs with less pain and joint load. The purpose is safe whole-body exercise when land walking is hard. Water supports body weight and provides gentle resistance. The mechanism is buoyancy that reduces impact on joints, plus water resistance that strengthens muscles and helps circulation without over-straining fragile nerves. PMC+1

9. Assistive walking devices
Canes, crutches, or walkers are sometimes needed when weakness and balance problems increase. The purpose is safer mobility and energy saving, especially outdoors or on long distances. The mechanism is load sharing: part of body weight is transferred through the device, increasing base of support and allowing slower, more controlled steps. nhs.uk+1

10. Hand splints and adaptive hand devices
Soft splints or custom braces can stabilize weak wrists and fingers. Adaptive devices like built-up pens, zipper pulls, or jar grippers make tasks easier. The purpose is to reduce fatigue and pain in the hands and to protect joints from deformity. Mechanistically, they support alignment and improve leverage so less muscle force is needed for fine tasks. Physiopedia+1

11. Pain psychology and cognitive-behavioral therapy (CBT)
Living with chronic nerve pain and disability is stressful. CBT and pain-education programs teach relaxation, pacing, and coping skills. The purpose is to lower the emotional “volume” of pain and improve sleep and mood. The mechanism is changing how the brain interprets pain signals, reducing catastrophizing, and improving self-management behaviors. Province of British Columbia+1

12. Energy conservation and fatigue management
Therapists teach planning of the day, using sits instead of stands, and breaking big tasks into smaller parts. The purpose is to reduce exhaustion and allow important activities to be done when energy is highest. Mechanistically, this lowers the total repeated load on weak muscles and nerves, slowing the build-up of fatigue and pain. PMC+1

13. Home safety and fall-prevention modifications
Simple changes such as removing loose rugs, improving lighting, adding grab bars, and using non-slip mats lower injury risk. The purpose is to prevent fractures and head injuries from falls. The mechanism is environmental control: reducing trip hazards and giving more stable hand holds to support weak legs and poor sensation. nhs.uk+1

14. Podiatry and regular foot care
A podiatrist trims nails, removes calluses, and treats minor skin problems early. The purpose is to prevent ulcers, infections, and painful pressure points on numb feet. The mechanism is frequent inspection plus early treatment, which stops small problems from becoming serious wounds in areas with poor protective sensation. nhs.uk+1

15. Respiratory and posture training (if needed)
Some people with advanced CMT develop breathing muscle weakness or spinal deformity. Respiratory therapists teach breathing exercises, cough techniques, and sometimes non-invasive ventilation. The purpose is to keep oxygen and carbon dioxide at safe levels and reduce infections. The mechanism is improving chest expansion, clearing mucus, and supporting weak breathing muscles. ScienceDirect+1

16. Weight management and general fitness
Healthy body weight and regular low-impact cardio (such as cycling or swimming) reduce stress on weak legs and improve heart health. The purpose is to make walking easier and reduce joint pain. Mechanistically, less body weight means lower force on feet and ankles, and better cardiovascular fitness improves stamina and recovery. Physiopedia+1

17. Psychological counseling and support groups
Talking with counselors and others who have CMT can reduce anxiety and depression. The purpose is emotional support, building realistic hope, and encouraging adherence to therapy. The mechanism is sharing experiences, normalizing feelings, and learning coping strategies, which lowers stress hormones that can worsen pain perception. PMC+1

18. Genetic counseling for patient and family
Genetic counselors explain inheritance patterns, testing options, and family planning choices. For CMT2U (autosomal dominant), each child has a 50% chance of inheriting the variant. The purpose is informed decisions and reduced guilt or confusion. The mechanism is clear education about the MARS1 mutation and its risks, using family trees and test results. ZFIN+2Monarch Initiative+2

19. School and workplace accommodations
Extra time for tasks, modified physical education, ergonomic chairs, or remote work can be arranged. The purpose is to keep education and career on track despite physical limits. Mechanistically, adjustments reduce physical strain and fatigue, so the person can focus effort on learning and job performance rather than fighting their body. PMC+1

20. Patient education and self-management training
Understanding CMT2U helps people notice early changes, avoid harmful activities, and use treatments correctly. The purpose is shared decision-making and better long-term outcomes. The mechanism is improving health literacy so the person can monitor symptoms, follow exercise programs, protect feet, and seek help early for new problems. nhs.uk+2PMC+2

---

Drug Treatments

These medicines are mostly approved for neuropathic pain or related problems (like spasticity or depression) rather than specifically for CMT2U. Doses are typical adult ranges from FDA labels and pain guidelines; exact dosing must always be individualized by a doctor. Texas Health and Human Services+4FDA Access Data+4FDA Access Data+4

1. Pregabalin (Lyrica)
Pregabalin is an anticonvulsant used widely for neuropathic pain (for example, diabetic neuropathy and post-herpetic neuralgia). Usual adult doses range from about 150 to 600 mg per day in divided doses, adjusted slowly. It works by binding to alpha-2-delta subunits on calcium channels in nerve cells, reducing release of pain-signaling chemicals. Main side effects include dizziness, sleepiness, weight gain, and swelling of legs. FDA Access Data+2FDA Access Data+2

2. Gabapentin (Neurontin, Gralise, Horizant)
Gabapentin is another anticonvulsant used for neuropathic pain. Typical total daily doses are in the range of 900–3600 mg split into three doses, or once-daily extended-release forms, titrated gradually. It reduces abnormal firing in damaged nerves by binding to similar calcium-channel subunits. Side effects include dizziness, tiredness, swelling, and sometimes mood changes; labels warn about risk of suicidal thoughts and breathing problems with other depressants. Province of British Columbia+4FDA Access Data+4FDA Access Data+4

3. Duloxetine (Cymbalta)
Duloxetine is a serotonin-noradrenaline reuptake inhibitor (SNRI) approved for diabetic neuropathic pain and fibromyalgia. Usual adult neuropathic pain dose is 60 mg once daily; some patients start at 30 mg for one week. It increases levels of serotonin and noradrenaline in pain pathways in the brain and spinal cord. Common side effects are nausea, dry mouth, sleepiness, sweating, and sometimes increased blood pressure or liver concerns. FDA Access Data+2FDA Access Data+2

4. Amitriptyline (Elavil and generics)
Amitriptyline is a tricyclic antidepressant often used at low doses for nerve pain. Typical night-time doses for neuropathic pain begin around 10–25 mg and may slowly rise to 75–100 mg if tolerated. It blocks reuptake of serotonin and noradrenaline and also has antihistamine and anticholinergic effects, which help pain but cause dry mouth, constipation, weight gain, and drowsiness. It must be used carefully in heart disease and older adults. Province of British Columbia+1

5. Nortriptyline
Nortriptyline is similar to amitriptyline but somewhat better tolerated in many people. Doses for pain usually start around 10–25 mg at night and increase slowly. The purpose is to reduce burning, shooting pain and improve sleep. The mechanism is mixed serotonin and noradrenaline reuptake inhibition with fewer sedating effects than amitriptyline, though dry mouth, constipation, and heart rhythm changes remain possible. Province of British Columbia+1

6. Venlafaxine (extended-release)
Venlafaxine, another SNRI, is sometimes used off-label for neuropathic pain when duloxetine is not tolerated. Doses for pain often range from 75–225 mg daily, adjusted gradually. It raises serotonin and noradrenaline levels, dampening pain transmission in the spinal cord. Side effects can include nausea, insomnia, sweating, and increased blood pressure, so monitoring is needed. Province of British Columbia+1

7. Carbamazepine
Carbamazepine is an anticonvulsant used for trigeminal neuralgia and sometimes other neurogenic pains. Doses typically start low (100–200 mg daily) and increase as tolerated. It stabilizes over-excited nerve membranes by blocking sodium channels. Its side effects can be serious, including low blood counts, liver problems, rash, and drug interactions, so blood tests and close supervision are needed. Province of British Columbia+1

8. Oxcarbazepine
Oxcarbazepine is chemically related to carbamazepine and sometimes used when carbamazepine is not tolerated. Doses for neuropathic pain are individualized, often 600–1200 mg daily. It also blocks voltage-gated sodium channels in nerve cells, calming ectopic discharges. Side effects include low sodium levels, dizziness, and fatigue. It may have fewer blood and liver problems than carbamazepine but still needs monitoring. Province of British Columbia+1

9. Tramadol
Tramadol is a weak opioid with SNRI activity sometimes used short-term for severe neuropathic pain flares. Typical adult doses are 50–100 mg every 4–6 hours (max daily dose set by a doctor), with caution. It acts on mu-opioid receptors and also inhibits serotonin and noradrenaline reuptake. Side effects include nausea, dizziness, constipation, risk of dependence, and seizures, especially with high doses or other serotonergic drugs. Province of British Columbia+1

10. Topical lidocaine 5% patch or gel
Lidocaine patches can be applied over painful areas of the feet to reduce localized neuropathic pain. Usual use is up to 12 hours on and 12 hours off per day on intact skin. The mechanism is local blockade of sodium channels in small nerve fibers, reducing firing without systemic effects. Side effects are usually mild skin redness or irritation. Province of British Columbia+1

11. High-strength capsaicin topical treatment
Capsaicin creams and patches use chili-pepper extract to desensitize pain fibers. In high-strength patch form, it is applied in clinic for a limited time, producing long-lasting pain relief in some patients. The mechanism is overstimulation then temporary loss of function of TRPV1-positive nociceptors. Burning and redness at the application site are common, so careful supervision is required. Province of British Columbia+1

12. Non-steroidal anti-inflammatory drugs (NSAIDs)
Drugs like ibuprofen and naproxen do not treat neuropathic pain itself but help muscle and joint pain that comes from abnormal walking. Doses vary by drug and country guidelines. They block cyclo-oxygenase enzymes and lower prostaglandin production, reducing inflammation and pain. Side effects can include stomach irritation, kidney strain, and increased cardiovascular risk with long-term use. Texas Health and Human Services

13. Acetaminophen (paracetamol)
Acetaminophen is often used for mild musculoskeletal pain in CMT. Typical adult maximum daily dose is kept within local guideline limits to protect the liver. Its exact mechanism is not fully understood but likely involves central COX inhibition and effects on serotonin pathways. It is usually well tolerated but can cause severe liver damage in overdose or in people with pre-existing liver disease. Texas Health and Human Services+1

14. Baclofen
Baclofen is a muscle relaxant acting as a GABA-B receptor agonist in the spinal cord. In CMT2U, it may be used if there is spasticity or severe cramps. Doses start low (for example 5 mg three times daily) and increase slowly. It reduces reflex muscle over-activity. Side effects include sleepiness, weakness, and dizziness; sudden withdrawal can cause serious reactions. EMJ Reviews+1

15. Tizanidine
Tizanidine is another antispasticity medicine, working as an alpha-2 adrenergic agonist. It reduces excess muscle tone and spasms with smaller effect on normal strength. Doses are gradually titrated, often starting at 2–4 mg. It can cause low blood pressure, dry mouth, and sleepiness, and must be used cautiously with liver disease. Texas Health and Human Services+1

16. Botulinum toxin injections
In some cases of severe focal deformity or painful spasms, botulinum toxin may be injected into overactive muscles. The purpose is to temporarily weaken these muscles and allow better balance between agonist and antagonist. The mechanism is blocking acetylcholine release at the neuromuscular junction. Effects last about 3–4 months; side effects include local weakness and, rarely, spread of toxin effect. ScienceDirect+1

17. Antidepressants for mood (SSRIs/SNRIs)
Living with a progressive nerve disease can cause depression and anxiety. SSRIs or SNRIs (like duloxetine or others) may be prescribed mainly for mood but also indirectly reduce pain distress. Doses and choices follow depression guidelines. These drugs adjust serotonin and/or noradrenaline levels in the brain. Side effects vary but can include nausea, sleep changes, and sexual dysfunction. Psychopharmacology Institute+1

18. Sleep aids (short-term, non-drug first)
If pain and cramps disturb sleep, doctors may use short-term medications (for example, low-dose sedating antidepressants or melatonin) after non-drug measures. The purpose is to restore restorative sleep, which improves pain tolerance and energy. Mechanisms vary, from adjusting circadian rhythms to enhancing GABA. All sleep medicines carry risks of dependence or next-day drowsiness, so doses and duration must be strictly limited. Province of British Columbia+1

19. Vitamin B12 injections (for proven deficiency)
If tests show low vitamin B12, injections or high-dose oral therapy may be given. The purpose is to correct a treatable cause of additional neuropathy on top of CMT2U. B12 is required for myelin repair and DNA synthesis in nerves; replacing it can slow or partly reverse deficiency-related nerve damage. Side effects are usually mild, but treatment must be guided by lab results. Province of British Columbia+1

20. Pain-management “multimodal” plans
Often several medicines at lower doses are combined with non-drug therapies rather than one high-dose drug. The purpose is better pain control with fewer side effects. Mechanistically, using different pathways—anticonvulsants, SNRIs, topical agents, and psychological therapies—targets pain in multiple places in the nervous system, which can be more effective and safer. Province of British Columbia+2Texas Health and Human Services+2

---

Dietary Molecular Supplements

(These are general nerve-health supplements studied mainly in other neuropathies. Evidence quality varies; always confirm safety with a doctor.) Province of British Columbia+1

1. Alpha-lipoic acid
Alpha-lipoic acid is an antioxidant used in some countries for diabetic neuropathy. Typical oral doses in studies are around 600 mg per day. It helps by reducing oxidative stress in nerves and improving blood flow. This may lessen burning pain and numbness, although evidence for hereditary neuropathies like CMT2U is limited. Possible side effects include nausea and low blood sugar in people with diabetes.

2. Acetyl-L-carnitine
Acetyl-L-carnitine helps mitochondria turn fat into energy. Doses in neuropathy studies often range from 1–3 g per day, divided. It may support nerve regeneration and reduce pain by improving energy production in damaged axons. Some people experience mild stomach upset. Because long-term safety data are limited, use should be supervised by a clinician. Province of British Columbia+1

3. Coenzyme Q10
Coenzyme Q10 is another mitochondrial cofactor and antioxidant. Supplement doses commonly range from 100–300 mg per day with food. It may improve cellular energy and protect nerve cells from oxidative damage. Evidence is stronger in mitochondrial diseases and heart failure than in CMT, but its safety profile is generally good; side effects include mild stomach discomfort. ScienceDirect+1

4. Omega-3 fatty acids (EPA/DHA)
Fish-oil omega-3s support cell membrane health and have anti-inflammatory effects. Doses in studies are often 1–3 g of combined EPA/DHA daily. They may help nerve membranes remain flexible and reduce low-grade inflammation around nerves and joints. They can thin the blood a little, so they must be used carefully with anticoagulants. Province of British Columbia+1

5. Vitamin D3
Vitamin D deficiency is common and worsens muscle weakness and bone health. When tests show low levels, typical replacement doses range from 800–2000 IU daily or higher short-term regimens. Vitamin D supports calcium handling, muscle function, and the immune system. Excessive doses can cause high calcium, so dosing should follow lab-guided medical advice. Province of British Columbia+1

6. Benfotiamine (vitamin B1 derivative)
Benfotiamine is a fat-soluble form of vitamin B1 studied in diabetic neuropathy. Doses in trials often use 150–300 mg twice daily. It helps reduce harmful sugar-related products called advanced glycation end products (AGEs) and supports nerve metabolism. Side effects are usually mild gastrointestinal symptoms. Evidence in hereditary neuropathy is limited but mechanistically reasonable. Province of British Columbia+1

7. Methylcobalamin (active B12)
Methylcobalamin is an active form of vitamin B12 used in some neuropathy supplements. Oral doses may be 1000–2000 mcg daily, or injections if there is clear deficiency or absorption problems. It supports myelin repair and DNA synthesis in nerves. Over-the-counter use should be coordinated with blood-test monitoring. Province of British Columbia+1

8. Pyridoxal-5-phosphate (active vitamin B6)
Small doses of vitamin B6 (often under 50 mg per day) are included in nerve formulas. It helps many enzymes in nerve metabolism. However, high doses of B6 for long periods can themselves cause neuropathy, so it must be used in modest, supervised amounts only. Province of British Columbia+1

9. Curcumin (from turmeric)
Curcumin is an anti-inflammatory and antioxidant compound. Typical supplement doses range from 500–1000 mg per day of standardized extract with piperine to improve absorption. It may reduce inflammatory pain and possibly protect nerves from oxidative stress. Side effects include stomach upset or gallbladder discomfort in some people. Province of British Columbia+1

10. Magnesium
Magnesium supports muscle and nerve function and may reduce cramps. Oral doses in supplements are often 200–400 mg elemental magnesium per day, depending on kidney function. It works by modulating calcium channels and NMDA receptors. Too much can cause diarrhea, and people with kidney disease must use it only under medical supervision. Province of British Columbia+1

---

Immunity-Booster, Regenerative and Stem-Cell-Related Drugs

Important: None of these are standard or widely approved treatments for CMT2U. They are areas of research or used mainly in other conditions. They should never be tried outside qualified clinical trials or specialist care. Taylor & Francis Online+5PMC+5Charcot-Marie-Tooth Disease+5

1. Mesenchymal stem-cell therapies (experimental)
Mesenchymal stem-cell injections are being studied for several CMT types. Early trials suggest possible improvements in gait and balance with certain cord-tissue or mesenchymal stem-cell products, but safety, dosing, and long-term benefits remain unclear. Proposed mechanisms include releasing growth factors, calming inflammation, and supporting nerve repair. At present, such therapies should only be received inside regulated clinical trials, not in commercial “stem-cell clinics.”

2. EN001 and other investigational stem-cell products
Reports describe a product called EN001 being tested in CMT1A and CMT1E. It uses stem cells prepared under strict protocols and given intravenously or intrathecally in trials. The purpose is to slow progression and improve walking. The mechanism is still under study, focusing on trophic support to damaged nerves. There is no approved indication yet; participation is limited to trial centers. AFM Téléthon+1

3. Gene-therapy approaches for CMT
Several gene-therapy programs target other CMT subtypes (for example, CMT2S, CMT4J, CMT4C). They typically use viral or plasmid vectors to correct or silence faulty genes. The purpose is disease modification at the root cause. For CMT2U, gene therapy remains theoretical but could eventually aim to correct MARS1 function. Mechanisms include AAV-mediated gene replacement or gene silencing. These treatments are still in pre-clinical or early clinical study. Taylor & Francis Online+4CMT Research Foundation+4Institut Myologie+4

4. PXT3003 (investigational combination)
PXT3003 is a fixed-dose combination of baclofen, naltrexone, and sorbitol studied mainly in CMT1A phase 2/3 trials, where it showed signals of functional improvement. It is not approved yet but aims to normalize overexpressed PMP22 and improve nerve conduction. Its mechanism in CMT2U is unknown and likely limited, but it illustrates the trend toward targeted combination therapies in hereditary neuropathies. DrugBank+5PubMed+5ClinicalTrials.gov+5

5. Neurotrophic factors and growth-factor-based drugs (pre-clinical)
Neurotrophic molecules such as neurotrophin-3 and other growth factors have been tested in animal models of CMT. They aim to protect axons and myelin and stimulate regeneration. Delivery methods and side-effects have limited progress so far. For CMT2U, these remain experimental laboratory approaches. The mechanism is direct support of neuron survival and myelination. PMC+2ScienceDirect+2

6. Immunomodulating drugs (only for misdiagnosis or overlap)
Drugs like intravenous immunoglobulin (IVIG) or corticosteroids help inflammatory neuropathies (like CIDP), not genetic CMT2U. Sometimes they are tried if there is diagnostic uncertainty. Their mechanism is calming autoimmune attacks on myelin or axons. In confirmed pure CMT2U, they have not shown consistent benefit and are not standard; they are mentioned mainly to clarify that “immune-boosting” therapy is usually not helpful in this genetic disease. ScienceDirect+1

---

Surgical Options

1. Soft-tissue release for tight tendons
Orthopedic surgeons may lengthen the Achilles tendon or release tight soft tissues around the ankle when contractures make the foot point downwards. The purpose is to allow the foot to sit flatter in shoes and AFOs, improving walking and reducing skin pressure. Mechanistically, cutting and lengthening specific tendon sections reduces abnormal pull on the joints. ScienceDirect+1

2. Tendon transfer for foot drop
In tendon-transfer surgery, a stronger tendon (such as the tibialis posterior) is rerouted to lift the front of the foot. The purpose is to replace weak dorsiflexor muscles and reduce tripping. The mechanism is redirecting muscle force from a still-working muscle so it now helps raise the toes during walking, improving step clearance. ScienceDirect+1

3. Corrective osteotomy for foot deformity
If the foot bones become fixed in a high-arched (cavus) or twisted position, bone-cutting (osteotomy) procedures can realign them. The purpose is to create a more plantigrade (flat) foot that fits shoes and spreads weight evenly. Mechanistically, the surgeon cuts and repositions bones, then holds them with screws or plates until they heal. ScienceDirect+1

4. Joint fusion (arthrodesis) for severe instability
In very unstable or painful joints that cannot be corrected with soft-tissue procedures, fusion surgery may be used. Bones are fixed together so the joint no longer moves. The purpose is pain relief and greater stability, even though flexibility is reduced. This can make walking more predictable and reduce risk of sprains and falls. ScienceDirect+1

5. Spine surgery for severe scoliosis
Some people with advanced CMT develop significant spinal curvature. When bracing and therapy fail, spinal fusion and instrumentation can be needed. The purpose is to prevent further deformity, protect lung function, and reduce pain. The mechanism is straightening and stabilizing the spine with rods and screws until fusion occurs. ScienceDirect+1

---

Prevention Strategies

Because CMT2U is genetic, we cannot fully prevent it. However, we can prevent avoidable worsening and complications. nhs.uk+2ScienceDirect+2

1. Avoid known neurotoxic drugs (for example, certain chemotherapy drugs like vincristine) by reminding every doctor about CMT.

2. Keep a healthy weight to reduce stress on weak feet and ankles.

3. Wear well-fitting shoes and AFOs to prevent pressure sores and falls.

4. Do regular stretching and strengthening exercises as prescribed.

5. Check feet daily for blisters, cuts, or calluses and treat problems early.

6. Keep blood sugar and other chronic conditions well controlled.

7. Make home safety changes (good lighting, no loose rugs) to reduce falls.

8. Stay physically active with low-impact exercise to maintain stamina.

9. Keep vaccinations up to date (for example flu and pneumonia) to reduce infection-related weakness.

10. Use genetic counseling for family planning and early detection in relatives.

---

When to See a Doctor

You should see a doctor or neurologist regularly for planned reviews and urgently if there are new or rapidly worsening symptoms. Go for urgent evaluation if you notice sudden loss of walking ability, new severe weakness in arms or legs, sudden bladder or bowel problems, new swallowing or breathing difficulty, rapidly increasing scoliosis, or uncontrolled pain or mood changes. Early review is also important if you develop frequent falls, non-healing foot wounds, signs of infection, or if new medicines seem to worsen weakness or balance. Regular visits allow updating braces, therapy, and pain plans in line with your current function. PMC+3nhs.uk+3ScienceDirect+3

---

What to Eat and What to Avoid

1. Eat a balanced diet rich in vegetables, fruits, whole grains, lean protein, and healthy fats to support overall nerve and muscle health.

2. Include sources of B vitamins (whole grains, eggs, dairy, legumes) and omega-3 fats (fatty fish, flaxseed) to support nerve membranes. Province of British Columbia+1

3. Stay well hydrated, as mild dehydration can worsen fatigue and cramps.

4. Limit highly processed foods high in sugar and refined carbs that promote weight gain and inflammation.

5. Avoid excessive alcohol, which directly damages peripheral nerves and can worsen neuropathy. Province of British Columbia+1

6. Limit very high doses of vitamin B6 supplements unless closely supervised, because they can cause neuropathy.

7. Choose calcium- and vitamin-D-rich foods (dairy or fortified alternatives, leafy greens) to protect bones weakened by reduced mobility.

8. Keep salt intake moderate to reduce swelling from some pain medicines.

9. Avoid fad “nerve detox” diets or unregulated “stem-cell” or “immune-boost” products sold online; they often lack evidence and can be harmful. Labiotech.eu+1

10. If you are underweight or losing weight due to fatigue or depression, ask for a dietitian review to design high-nutrient meals and snacks.

---

Frequently Asked Questions

1. Is CMT2U different from other types of Charcot-Marie-Tooth disease?
Yes. CMT2U is an axonal form linked to MARS1 gene mutations. It mainly damages the long nerve fiber rather than the myelin. Symptoms often resemble other CMT2 forms (foot drop, weakness, sensory loss), but the genetic cause is different, which may affect future gene-based treatments. ZFIN+2Monarch Initiative+2

2. Can CMT2U be cured today?
There is no cure at present. Available treatments aim to control symptoms, maintain function, and prevent complications through therapy, braces, and pain management. Research in gene therapy, stem-cell approaches, and targeted drugs is active, but all are still experimental for CMT2U. Taylor & Francis Online+4ScienceDirect+4Institut Myologie+4

3. Will everyone with CMT2U need a wheelchair?
Not everyone will. CMT2U is usually slowly progressive, and many people remain able to walk, especially with good therapy, braces, and safe habits. Some people may need a wheelchair or scooter for long distances or later stages, which can actually improve independence and reduce fatigue rather than “giving up.” nhs.uk+2PMC+2

4. Is exercise safe, or can it damage my nerves more?
Appropriate low-to-moderate-intensity exercise designed by a physiotherapist is generally safe and beneficial. It strengthens muscles that still have working nerves and helps fitness. Very heavy or high-impact exercise that causes repeated injury or extreme fatigue should be avoided. Listening to your body and following professional guidance is key. Physiopedia+2PMC+2

5. Can children with CMT2U play sports?
Many children can take part in adapted sports such as swimming, cycling, or wheelchair sports. Contact sports or activities with high fall risk may need modifications. A pediatric neurologist and physiotherapist can advise on safe options and any protective equipment needed. Charcot-Marie-Tooth Disease+1

6. Are stem-cell clinics on the internet safe for CMT2U?
Most commercial stem-cell clinics are not part of regulated clinical trials and often lack solid safety or efficacy data. They can be very expensive and sometimes dangerous. It is safer to join properly approved research studies at academic or hospital centers if you qualify, and avoid “miracle cure” advertising. Vega Stem Cell+4PMC+4Cells4Life+4

7. Which pain medicine is “best” for CMT2U?
No single medicine is best for everyone. Drugs like pregabalin, gabapentin, duloxetine, or tricyclic antidepressants are common first-line options for neuropathic pain. Doctors choose based on age, other illnesses, side-effect risk, and personal response. Often a mix of lower-dose medicines plus non-drug therapies gives the best balance of relief and safety. PMC+3Province of British Columbia+3Texas Health and Human Services+3

8. Do supplements replace medicines and therapy?
Supplements can support overall health but usually give only modest benefit on their own. They do not replace physio, braces, or evidence-based pain medicines. Thinking of them as an “extra layer” on top of core treatments, rather than a substitute, is more realistic and safer. Province of British Columbia+1

9. Is pregnancy safe if I have CMT2U?
Many people with CMT have healthy pregnancies and children. However, symptoms (especially weakness and balance) may temporarily worsen due to weight gain and hormonal changes. There is also a 50% chance of passing the mutated gene to each child. Pre-pregnancy counseling with a neurologist and genetic counselor is very helpful. ZFIN+1

10. Can CMT2U affect breathing or heart function?
Most people with CMT have mainly limb involvement, but severe long-standing disease can occasionally involve breathing muscles or contribute to scoliosis that affects lungs. Heart muscle is usually not directly affected, but everyone should follow routine heart-health advice. Any new breathlessness, morning headaches, or snoring should prompt evaluation. ScienceDirect+2AFM Téléthon+2

11. How often should I see my neurologist?
Frequency depends on disease stage and stability, but yearly reviews are common when stable, with more frequent visits if symptoms are changing or treatments are being adjusted. Children may need closer follow-up to monitor growth, walking, and spine shape. nhs.uk+2ScienceDirect+2

12. Is CMT2U life-threatening?
Most people with CMT live near-normal lifespans. Disability and quality-of-life issues are more common than life-threatening complications. However, severe foot deformities, falls, infections, or rare breathing problems can be serious if not managed early. Regular multidisciplinary care greatly reduces these risks. nhs.uk+2MalaCards+2

13. Will gene therapy be available for CMT2U soon?
Gene therapy for CMT is advancing, with trials for several subtypes already underway. For CMT2U specifically, research is still at early, pre-clinical stages. It is impossible to give a date, but progress in related subtypes makes future MARS1-targeted therapies more likely. Staying linked with patient organizations helps you hear about new trials. Taylor & Francis Online+4Institut Myologie+4PMC+4

14. Can lifestyle really change my disease course?
Lifestyle cannot remove the genetic mutation, but it can strongly affect how much disability you experience. Regular therapy, safe activity, weight control, foot protection, and good mental health care can delay complications, reduce pain, and protect independence for many years. ISCT Cytotherapy+3Physiopedia+3PMC+3

15. Where can I find reliable information and support?
National CMT organizations, hospital neuromuscular clinics, and peer-reviewed medical sites are good sources. They provide guides on PT/OT, braces, research news, and support groups. Avoid sites promising quick cures or selling expensive unproven therapies. Your local neurologist or genetic counselor can help you identify trustworthy resources. Labiotech.eu+3Charcot-Marie-Tooth Association+3Charcot-Marie-Tooth Disease+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 22, 2025.